Form 8-K · Current report
News Corp 8-K, filed Aug 31, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000191
Summary
News Corp filed an 8-K reporting the information it provided to the Australian Securities Exchange on its buy-back program, under which it is authorized to repurchase up to $1 billion of its Class A and Class B common stock. The filing states that as of August 28, 2026, roughly $450.8 million of shares had been purchased under the program.
Key points
- News Corp is authorized to repurchase up to $1 billion in aggregate of its Class A and Class B common stock under a program authorized July 15, 2025.
- As of August 28, 2026, News Corp had bought back 11,345,444 shares for total consideration of about $292.9 million, including 50,801 shares the previous day for about $1.58 million.
- Prices paid under the program have ranged from $22.20 to $31.58 per share.
- News Corp states it has purchased approximately $450.8 million worth of Class A and Class B shares to date under the 2025 program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.